Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Iowa law expanding postpartum Medicaid coverage approved by federal government
Iowa’s plan to extend postpartum coverage for new mothers has been approved by the Center for Medicare and Medicaid Services ...
BioSpace1 天
Lilly Wins Medicare Coverage for Zepbound in Sleep Apnea
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, CMS says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Medicare and maternity: Is it covered?
For those who qualify for Medicare, coverage includes most pregnancy-related medical care. Medicare Part A provides coverage ...
Center on Budget and Policy Priorities1 天
State Efforts to Take Medicaid Health Coverage Away From People Likely to Resurface in 2025
Everyone, regardless of income, needs health care to survive and thrive, and most Americans agree that health care is a ...
Daily Journal4 天
Medicaid coverage of weight-loss drugs could cost Indiana up to $70 million a year
Indiana’s Medicaid program estimates the Biden administration’s proposal to expand coverage of weight-loss treatment for ...
thesiliconreview17 小时
Medicare Expands Coverage for Eli Lilly’s Zepbound Drug
Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...
Health Affairs25 天
Proposed Rule Would Expand Medicare And Medicaid Coverage For Anti-Obesity Medications
would result in expanded Medicare and Medicaid coverage for anti-obesity medications (AOMs). This expanded coverage would potentially include the new class of GLP-1 agonists, such as Wegovy.
Medicare Expands Coverage of Eli Lilly’s Weight-Loss Drug
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...